Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Intercept PharmaceuticalsTaro Pharmaceutical IndustriesAmarinInsmedKaruna Therapeutics
Price Information
Current Price$47.09$67.45$6.92$29.57$109.74
52 Week RangeHoldBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.
Analysis Score4.
Community Score3.
Dividend Score0.
Ownership Score1.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$74.64$96.00$17.23$42.00$117.73
% Upside from Price Target58.50% upside42.33% upside149.00% upside42.04% upside7.28% upside
Trade Information
Market Cap$1.55 billion$2.58 billion$2.67 billion$2.99 billion$2.87 billion
Average Volume1,330,69235,7206,399,0181,110,993313,055
Sales & Book Value
Annual Revenue$252 million$644.77 million$429.76 million$136.47 millionN/A
Price / Sales6.164.006.2121.89N/A
CashflowN/A$6.95 per shareN/AN/AN/A
Price / CashN/A9.71N/AN/AN/A
Book Value$1.57 per share$55.15 per share$1.63 per share$2.93 per share$16.65 per share
Price / Book29.991.224.2510.09N/A
Net Income$-344,680,000.00$244.24 million$-22,650,000.00$-254,340,000.00$-43,960,000.00
Trailing P/E RatioN/A10.61N/AN/AN/A
Forward P/E RatioN/A17.74N/AN/A
Net Margins-127.53%37.88%-3.67%-162.82%N/A
Return on Equity (ROE)-430.51%11.94%-4.05%-87.35%-18.24%
Return on Assets (ROA)-45.23%10.79%-2.45%-33.04%-15.83%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio10.32%N/AN/A1.74%0.01%
Current Ratio4.19%6.88%2.63%6.89%145.80%
Quick Ratio4.19%6.19%2.34%6.46%145.80%
Ownership Information
Institutional Ownership Percentage76.46%11.60%44.36%95.51%63.87%
Insider Ownership Percentage23.70%13.80%2.75%4.63%18.10%
Shares Outstanding32.94 million38.26 million385.49 million101.04 million26.13 million
Next Earnings Date8/5/2020 (Estimated)8/13/2020 (Estimated)7/29/2020 (Estimated)8/6/2020 (Estimated)8/13/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.